news
Union Health Minister J P Nadda recently assessed the advancements made by the Indian Pharmacopoeia Commission (IPC) during a recent review meeting. He applauded the IPC for reinforcing pharmacopoeial standards and pharmacovigilance, contributing significantly to the government's vision of a self-reliant and developed India. Recognized in 19 countries,
Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) has signed three Memorandums of Understanding with the Nagaland Medical Council, Nagaland State Drugs Control Administration (NSDCA), and Nagaland State Pharmacy Council. This collaboration aims to bolster pharmacovigilance and materiovigilance activities, improve adverse event reporting, and establish ADR monitoring centers. Additionally, the agreements aim to
MedSafetyWeek
India participated in the tenth edition of the global #MedSafetyWeek campaign from November 3-9, 2025, alongside 130 partner organizations worldwide. The campaign aimed to raise awareness about the importance of reporting suspected side effects of medicines, emphasizing that everyone has a role in ensuring medicine safety. Dr. V. Kalaiselvan and
Pharmacovigilance
The Central Council for Research in Ayurvedic Sciences (CCRAS) organized a two-day National Symposium on "Pharmacovigilance – Shishu Suraksha: Rashtra Suraksha" to mark World Patient Safety Day 2025. The event emphasized the importance of pharmacovigilance in ensuring patient safety, particularly for children. Key speakers highlighted the need for vigilance
Pharmacovigilance
The Indian Pharmacopoeia Commission inaugurated the 5th National Pharmacovigilance Week in New Delhi, focusing on patient safety and adverse drug reaction (ADR) reporting. The week-long campaign aims to encourage healthcare professionals and the public to report ADRs through digital platforms. Dr. Rajeev Singh Raghuvanshi, DCGI, emphasized the importance of patient
AYUSH
The Ministry of Ayush has implemented measures to strengthen consumer protection and curb unverified claims by Ayush product manufacturers. This includes the establishment of a Pharmacovigilance Program, adherence to the Drugs and Magic Remedies Act, public awareness campaigns, and the launch of the 'Ayush Suraksha' online portal to